Answers are grounded in this paper and cite their sources.
To the Editor: The remarkable effects of the tyrosine kinase inhibitor STI571 in chronic myeloid leukemia and acute lymphoblastic leukemia reported by Druker et al. (April 5 issue)1,2 are frequentl...
No takes yet. Share an insight, caveat, or question.
Brouard et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: